chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt with signs and symptoms of bronchospasm and difficulty breathing approximately 15-30 minutes after receiving vaccine. No prior history of such reaction after previous doses. No relief from albuterol. Pt went to ER and was given magnesium infusion and nebulizer treatments
HBP controlled with medication and on a statin; I received my 3rd Pfizer booster dose 4 months ago; I received my 3rd Pfizer booster dose 4 months ago; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (005570). The reporter is the patient.  A 73 year-old male patient received bnt162b2 (BNT162B2), administration date Aug2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "kidney cancer" (unspecified if ongoing), notes: 2 time cancer survivor, 1 kidney due to removal of kidney due to kidney cancer; "removal of kidney" (unspecified if ongoing), notes: 2 time cancer survivor, 1 kidney due to removal of kidney due to kidney cancer. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, Manufacturer unknown), for Covid-19 immunisation; Covid-19 vaccine (DOSE 2, Manufacturer unknown), for Covid-19 immunisation. The following information was reported: OFF LABEL USE (non-serious), IMMUNISATION (non-serious) all with onset Aug2021, outcome "unknown" and all described as "I received my 3rd Pfizer booster dose 4 months ago"; HYPERTENSION (non-serious), outcome "recovering", described as "HBP controlled with medication and on a statin". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of hypertension.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Patient presented to vaccine clinic being held at Clinic signed up for and was given the Covid vaccine and the Hi-Dose Flu vaccine.  Patient was not aware he had already received an influenza vaccine on 10/12/2023: Glaxosmithkline 7Z423 at same clinic.
RESTLESSNESS, INSOMNIA, DRY MOUTH X 1 WEEK
Approximately 10minutes after child received vaccines, child presented with cough, rash, itching.  Epi Jr 0.15mg IM administered, Neb treatment (Proventil/atrovent) administered, transferred to ER.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient.  A 61-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 24Oct2022 as dose 4 (booster), single (Lot number: GJ3275) at the age of 60 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 18Mar2021 as dose 1, single (Lot number: ER2613), in right arm, on 08Apr2021 as dose 2, single (Lot number: EW0151), in left arm and on 11Nov2021 as dose 3 (booster), single (Lot number: FH8028), in right arm for covid-19 immunisation. The patient's relevant medical history included: "PVCs" (unspecified if ongoing); "PACs" (unspecified if ongoing); "hx histoplasmosis with multiple nodules both lungs" (unspecified if ongoing); "chronic cough" (unspecified if ongoing); "known allergies: Penicillin" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Mar2023) Positive, notes: Tested positive for Covid 5 days after finishing paxlovid. Therapeutic measures were taken as a result of vaccination failure, covid-19 with Paxlovid from 05Mar2023 to 09Mar2023.; Sender's Comments: The efficacy of a product varies from one patient to another and can be affected by different factors; however, based on the temporal association and available information, a causal relationship between the events and suspect vaccine cannot be completely excluded.
First injection - had Covid rash 2 weeks later in left arm Second injection - 45 min after injection, constant clearing of throat and chest issue, took 25 mg benadryl, helped.  Next morning woke up with fever 100.8, nauseaus, headache, very tired and hot and cold.  next day, still fever and chills, tired and sweaty, headache.  Fever dropped in the afternoon of second day (3rd day after shot).  Hopefully better by next day or I will call my doctor.  taking Tylenol regularly.
Rapid-onset pain and erythema in R arm, with heat, fever to 100.4, myalgias, and pleuritic chest pain.
Approximately 3 hours later got suddenly very itchy all over left torso and underarm. No visible hives.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 7-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 06Nov2021 13:00 (Lot number: FK5127) at the age of 7 years as dose 1 (tris), single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: ALLEGRA. Past drug history included: No. The following information was reported: PRURITUS (non-serious) with onset 06Nov2021 16:00, outcome "recovered" (2021), described as "Approximately 3 hours later got suddenly very itchy all over left torso and underarm. No visible hives.". Therapeutic measures were not taken as a result of pruritus.  Additional information: The patient had not received any other vaccine within four weeks. The patient received other medication in two weeks (several days ago). The patient was not tested since vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had no known allergies.   Follow-Up: Follow-up attempts are completed. No further information is expected.
Severe Headache, Vomiting, high fever over 103 (my base temp is always 96.5-97)complete body aches, chills, lightheadedness tiredness. Headache better after 24 hrs, but now 4/24 it is back. The fever went down to 100 but today is inching back up. Still achy and extremely tired and I have lightheadedness and fainted today. Off and On I feel chest pain, but it could be anxiety.
JOINT PAIN  HANDS FEET, KNEES AND ALL OVER, SWELLING IN UPPER AND LOWER EXTREMITIES, FATIGUE, WEIGHT GAIN
Within 15 minutes of administration, patient began coughing and excessively clearing throat.  Pt reported tightness in throat.  RN administered 50mg liquid diphenhydramine and patient reported symptom improvement almost immediately . Pt remained for additional monitoring and left in stable condition with family member, who drove her to and from appointment.
By evening patient got really bad shakes, muscles started hurting like if had the Flu. Patient woke up with hives and still has them. Called the doctor on 7/5 and was given prescription for Prednisone but did not help. Hives kept moving around and showing in different parts of body. Patient had doctor visit on 7/10 and was not prescribed any new medication. Patient is smearing body with Triamcinolone (steroid cream) which at least is providing some relief. Currently, hives are going away, although at night they get inflamed and still has blotches all over body. Patient reports taking a lot of BENADRYL and anti-inflammation meds. Yesterday noticed that vertigo started. Today, in bed resting.
Shot on Thurs by Sat am itching in left arm progressing to burning sensation and redness by Sat pm.  Sunday itching and burning persisted with addition of intermittent sharp pain in area with rash and redness size of an orange.  Pain has persisted today, Monday.  Visited immediate care facility and they prescribed Valacyclovir 1000 mg, 3 times per day.  Am waiting another day before getting prescription to see if systems persist.  In the meantime using cold compress, baking soda and water paste, and lidocaine patch.
Intermittent bloody stools and fever for 48 hours. He was pale and septic appearing on 7/24 and was admitted to the hospital. Sepsis evaluation was negative and bloody stools resolved. Suspected intussusception.
pt recv vax & devel chickenpox;pt was seen by MD who noted a fever of 102.5, pruritus especially behind ears & approx 25 to 30 lesions scattered over body & head;dx w/chickenpox;
Pt devel erythematous area of induration (1.5cm) w/assoc heat & pain @ inject site w/in 2 days of Td; sx lasted for 1 wk;
On 9/10/01, LPN phoned at 13:45 stating that the pt had developed a temperature, achiness and sensitivity to light, post vax. Phoning the mother at 14:00, she stated that he no longer had a fever but was achy and sensitive to light. On 9/11/01, mother phoned this office and spoke with the Director, RN, and stated that the pt went to school and is no longer ill.
Systemic: Numbness (specify: facial area, extremities)-Mild, Additional Details: For about 10 minutes after the shot the patient had a tingling/heavy feeling in the arm that received the shot. After 10 minutes the feeling went awy.
Fever; This is a spontaneous report from a contactable consumer (patient's son). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, unknown formulation) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The caller stated that his mother had a fever after getting the Covid-19 vaccine. The outcome of the event was unknown.  Information related to lot/batch number has been requested.
A few days after the vaccine, I had an autoimmune flareup:  extreme exhaustion, neuropathy in my limbs, generally feeling terrible. This is consistent with flareups I've had in the past.
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20ZA and 042L20A.) for COVID-19 vaccination.     Concomitant products included OMEPRAZOLE, HYDROCHLOROTHIAZIDE, SULFAMETHOXAZOLE, TRIMETHOPRIM (SULFAMETHOXAZOLE AND TRIMETHOPRIM) and CITALOPRAM HYDROBROMIDE for an unknown indication.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown. Not Provided          No Concomitant medications were provided No Treatment information provided    This case was linked; Sender's Comments:  US-MODERNATX, INC.-second dose
Moderna COVID-19 Vaccine EUA that day of the vaccine, my right arm was sore, the area was red, warm to touch, and itching. about 30 hours after the vaccine, I hade fatigue, extreme body aches, chills, headache, and my arm still had the above reactions. this continued every evening until 1/17/21. at that time my arm where the shot was given was discolored (purplish looked like a bruise) and was flat. then on 1/21/21 I woke up and the area where the injection was given my arm was bright red, warm to touch, raised and itching.
Hearing like a light noise, a mild ring; Pain in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Hearing like a light noise, a mild ring) and VACCINATION SITE PAIN (Pain in the injection site) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 31-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced TINNITUS (Hearing like a light noise, a mild ring) and VACCINATION SITE PAIN (Pain in the injection site). At the time of the report, TINNITUS (Hearing like a light noise, a mild ring) and VACCINATION SITE PAIN (Pain in the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product use was provided by the reporter.  The patient reported the injection site pain is moderate, but tolerable. It has increased in the last 24 hours.  He's hearing a light noise, a mild ring. It's some type of frequency that's just constant, but it does not impair his hearing. Started the evening he got his vaccine.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
pt recv vax several years ago; subsequently pt devel autism; mom believed there was an association between pt sx & vax based on report heard from CNN;pt condition was considered disabling event;@ the time of reporting pt autism persisted;
Other 2 people who got the vaccine the same day as me, tested positive too; This is a spontaneous report from a contactable consumer. This is 3rd of 3 reports. A 25-year-non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection), via an unspecified route of administration in right arm on 16Mar2021 (Batch/Lot Number: EN6208) at single dose for covid-19 immunisation. There was no other vaccine in four weeks. No known allergies. No other medical history. The patient medical history and concomitant medications was not reported. Covid was not tested prior vaccination. Covid test type was Nasal Swab and test name was antigen. The patient tested positive for covid 9 days later from the day got the vaccine. The symptoms started 7 days later. Other 2 people who got the vaccine on the same day tested positive too. The events occurred on 22Mar2021 at 12:00 PM. The outcome of event was not recovered.  No follow-up attempts are possible. No further information is expected.
No additional adverse event; Unknown 4 month old patient was administered first ROTATEQ dose; This spontaneous report was received from a medical assistant concerning a 4-month-old patient. Information regarding the patient's concurrent conditions, medical history, historical drug and concomitant therapies was not provided.  On 13-JAN-2021, the patient was vaccinated with the first dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) oral route, lot #1688832 and expiration date 24-JUN-2021, for prophylaxis.  No additional adverse event was reported.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 30Sep2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 70 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "IBS-D" (unspecified if ongoing), notes: other medical history: IBS-D; "Diverticulitis" (unspecified if ongoing); "Known allergies: Penicillin" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical Course: Anti-viral COVID 19 Treatment Paxlovid from 12Jan2023 to 16Jan2023. Other medication in 2weeks: No.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Boosters 11/16/04. Next AM had large 6 x 4 cm area at site of MMR. Had fever of 101F, erythema at site of MMR and irritably. Returned 11/17/04 and was told to go to ER. Treated with Cephalexin and cortisone and decadine but no results received by mom. Saw doctor 11/18/05. No additional treatment given. Erythema resolved within 7 days. No further complication observed.
Fever up to 100.9 F; Sinus pressure; Body aches; Tiredness; Pain at injection site; This is a spontaneous report from a contactable consumer (patient). A 43-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL8982), via an unspecified route of administration in the left arm on 27Jan2021 at 16:30 at the age of 43 years old at a single dose for COVID-19 Immunization at health clinic/ administration facility. The patient's medical history included mild asthma, CT contrast agent allergy from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received other medications within 2 weeks of vaccination. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3248) at the age of 43 years old on 07Jan2021 at 12:30 pm in the left arm for COVID-19 Immunization. The patient's concomitant medication included montelukast, albuterol (Salbutamol) and beclomethasone. The patient experienced fever up to 100.9 F, sinus pressure, body aches, tiredness, pain at injection site on 28Jan2021 at 6:00 AM. The patient assessed the events as non-serious. No treatment was received in response to the adverse event. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Patient received immunizations 9-15-11. Mother reports today that on 9-20-11 she developed fever and a rash on her face and trunk lasting 3 days. Highest fever 101.3.
Information has been received from an office worker concerning a 71 year old female who on 28-NOV-2006 was vaccinated IM with a 0.5 ml dose of Pneumovax 23 (lot #655291/0985F).  There was no concomitant medication.  On 29-NOV-2006 the patient developed swelling, redness, pain and she was unable to lift her arm.  The patient sought medical attention and was treated with unspecified antibiotics.  There were no laboratory or diagnostic tests performed.  At the time of the report, the patient's swelling, redness and pain and inability to lift her arm persisted.  Additional information has been requested.
Onset of headache, mild fever, Cough and sore throat on 30 July 2021
Approximately 7 days after receiving flu vaccine, patient presents with few hive resembling spots on her lower back. Primary care physician subsequently diagnosed as shingles.
100 degree fever 24 hours after injection and injection site soreness. Two weeks later, now showing abnormal resting heart rate and suggested by ECG results as pericarditis.
This spontaneous report as received from a licensed practical nurse refers to her currently 56 year old sister. On an unspecified date, the patient was vaccinated with a dose of ZOSTAVAX (lot number, route, dose, site not reported). The patient had a reaction to the ZOSTAVAX. Her arm became huge and red. The outcome of the events was unknown. This is one of several reports received from the same source. Additional information has been requested.
got shingles 3 days after the getting the first caccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (got shingles 3 days after the getting the first vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (got shingles 3 days after the getting the first vaccine). At the time of the report, HERPES ZOSTER (got shingles 3 days after the getting the first vaccine) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was unknown.   No relevant concomitant medications was reported. Treatment information was not provided.   Reporter did not allow further contact
difficulty breathing; tightness in chest; tingling in face; headache; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (difficulty breathing), CHEST DISCOMFORT (tightness in chest), PARAESTHESIA (tingling in face) and HEADACHE (headache) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced DYSPNOEA (difficulty breathing), CHEST DISCOMFORT (tightness in chest), PARAESTHESIA (tingling in face) and HEADACHE (headache). At the time of the report, DYSPNOEA (difficulty breathing), CHEST DISCOMFORT (tightness in chest), PARAESTHESIA (tingling in face) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment details were not provided.
One day post vax, the pt developed hives, experienced a sore left thigh and a swollen left knee. Seen at the hospital and was told it was a delayed reaction to Prevnar. Hives lasted for 1 week and pain in knee lasted 5-6 days.
Information has been received from a registered nurse referring to a patient of unknown age and gender. The patient did not experience temperature excursion previously. On 19-APR-2016 the patient was vaccinated with a dose of improperly stored PROQUAD (Merck) (dose and route were unknown, lot #: L50910, expiration date: 14-JUN-2017, therapy type: digital data logger). The vaccine was exposure on 9.9 Fahrenheit (F) for 1 hour and 20 minutes. No adverse events were reported. This case as one of several cases received from the same reporter. Additional information has been requested.
I am a 67 yr old extremely healthy vegan woman, runner.  I haven't been to the doctor for an illness in over 12 yrs.  After the 4th Moderna booster I got extreme soreness in my 3rd and 4th rt toes.  I thought it was from running with new shoes.  A week later pins and needles started in both feet, primarily my left, and some pins and needles in my hands.  The pins and needles have never subsided.   I've had insomnia and feelings like a buzzing and electric current going through my body for hours at a time.  I have been suicidal, several times, which I have never been before in my life.  It has been 5 months now and this is continuing.  I found a vaccine forum online where thousands of others are reporting similar symptoms.  Sometimes I'm okay with it and other times I'm just holding on.  I am pro-vaccine and feel it has saved 100s of thousands of lives, but this has affected me terribly.  I hope that the FDA and CDC can help us.